✦ LIBER ✦

511 HBSAG LEVELS DECLINE DURING PEGINTERFERON ALFA-2A [40KD] (PEGASYS) TREATMENT IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B FAVORS 6 MONTHS POST-TREATMENT RESPONSE: PERSEAS COHORT INTERIM ANALYSIS

✍ Scribed by I. Goulis; E. Akriviadis; S. Karatapanis; M. Deutsch; G. Dalekos; M. Raptopoulou-Gigi; K. Mimidis; G. Germanidis; C. Triantos; C. Drakoulis; A. Chounta; F. Tsoplou; E. Zintzaras; G. Bakalos; G. Papatheodoridis

Book ID: 117380723
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 181 KB
Volume: 56
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(12)60524-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

714 HBSAG LEVELS DURING THE FIRST 24 WEE

714 HBSAG LEVELS DURING THE FIRST 24 WEEKS OF PEGINTERFERON ALFA-2A [40KD] (PEGASYS) TREATMENT IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B: THE PERSEAS COHORT

✍ I. Goulis; E. Akriviadis; S. Karatapanis; M. Deutsch; G. Dalekos; M. Raptopoulou 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 58 KB

1027 INTRAHEPATIC HBSAG PREDICTS TREATME

1027 INTRAHEPATIC HBSAG PREDICTS TREATMENT RESPONSE IN HBEAG NEGATIVE CHRONIC HEPATITIS B (CHB) PATIENTS TREATED WITH PEGINTERFERON ALFA-2A AND ADEFOVIR; AN INTERIM ANALYSIS

✍ Takkenberg, B.; De Niet, A.; Terpstra, V.; Zaaijer, H.; Weegink, C.; Koot, M.; D 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

P.112 Response is sustained two years po

P.112 Response is sustained two years post-treatment in the majority of patients with HBeAg-negative chronic hepatitis B treated with peginterferon alpha-2a (40KD) [PEGASYS®]

✍ P. Marcellin; F. Bonino; G.K.K. Lau; P. Farci; C. Yurdaydin; T. Piratvisuth; R. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 281 KB